MDM2 antagonists as a novel treatment option for acute myeloid leukemia: perspectives on the therapeutic potential of idasanutlin (RG7388)

Khurana A, Shafer DA

OncoTargets and Therapy 2019, 12:2903-2910

Published Date: 16 April 2019